June 25-29, 2021
81st Annual American Diabetes Association Scientific Sessions
Below are upcoming events in LIST view. To the right, you can click the icon to see MONTH or DAY view.Â
You can click the left arrow “<" to see older previous events.
Loading view.
June 29, 2021
LifeSci Nordic Biotech Summit
August 12, 2021
Zealand Pharma Interim Report First Half 2021
Zealand Pharma hosted a conference call on August 12 at 4pm CET (10am ET) to present first half results for 2021.
Presenting during the call were President and Chief Executive Officer Emmanuel Dulac, Senior Vice President and Chief Financial Officer Matt Dallas, and Executive Vice President and Chief Medical Officer Adam Steensberg.
September 7, 2021
Goldman Sachs 11th Annual Biotech Symposium
November 11, 2021
Zealand Pharma Interim Report Third Quarter 2021
Zealand Pharma hosted a conference call on November 11 at 4 pm CET (10 am ET) to present third quarter results for 2021.
Presenting on the call were President and Chief Executive Officer Emmanuel Dulac, President of Zealand Pharma US Frank Sanders, Senior Vice President and Chief Financial Officer Matt Dallas, and Executive Vice President and Chief Medical Officer Adam Steenberg.
November 18, 2021
Jefferies London Healthcare Conference
January 10, 2022
H.C. Wainwright BIOCONNECT 2022 Conference
March 10, 2022
Zealand Pharma Annual Report 2021
Zealand Pharma hosted a conference call on March 10 at 4pm CET (10am ET) to present full year results for 2021.
Presenting during the call was President and Chief Executive Officer Emmanuel Dulac, Senior Vice President and Chief Financial Officer Matt Dallas, Executive Vice President and Chief Medical Officer Adam Steensberg, and President of Zealand Pharma U.S. Frank Sanders
April 11, 2022
21st Annual Needham Virtual Healthcare Conference
May 12, 2022
Zealand Pharma Interim Report First Quarter 2022
Zealand Pharma hosted a conference call on May 12 at 4 pm CET (10 am ET) to present first quarter results for 2022
Presenting on the call was President and Chief Executive Officer Adam Steensberg and Senior Vice President and Chief Financial Officer Matt Dallas